CureDuchenne and NS Pharma: VILTEPSO

This is a pre-recorded webinar with CureDuchenne, NS Pharma and guest speaker Dr. Mathula Thangarajh.

Topics include:

• Clinical evidence to support early initiation of DMD treatment

• The role of exon skipping in the treatment of DMD

• The efficacy of VILTEPSO for the treatment of DMD

• The safety and tolerability profile of VILTEPSO